5KJ-14473-43103 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-27
Registered in v-safe
2021-02-27
Dose 1 — Pfizer-BioNTech
2021-02-27
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-28
Survey response — days 1–6 daily, dose 1
MedDRA: Blindness, Deafness, Dizziness, Dyspnoea — Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Dizziness and lightheadedness, loss of hearing and vision, difficulty breathing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-28
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-03-01
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Nausea

Adult check-in
2021-03-02
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Nausea

Adult check-in
2021-03-03
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-03-03
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-03-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Nausea

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-06
Health check-in — day 7, dose 1
Feeling: Fair · Headache

Adult check-in
2021-03-13
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-17
Dose 2 — Pfizer-BioNTech
2021-03-17
Health check-in — day 0, dose 2
Feeling: Good · Nausea

Adult check-in
2021-03-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Nausea

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-27	Pfizer-BioNTech
2	2021-03-17	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-02-28	priority 2/3
2021-03-03	priority 2/3

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-28

Systemic reaction (other): Dizziness and lightheadedness, loss of hearing and vision, difficulty breathing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Blindness	✓	✓	✓
SRO	Deafness	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release